Steven Gelone - President and COO, Nabriva Therapeutics Plc

As of January 10, 2022


Steven Gelone Net Worth

  • Net worth is estimated to be at least $14.37K
  • Owns at least 22,740 units of Nabriva Therapeutics Plc stock
  • Sold an estimated value of $43.81K in the last 5 years at Nabriva Therapeutics Plc

Steven Gelone Compensation at Nabriva Therapeutics Plc in 2020

  • Earned a $486,300 salary
  • Received a total compensation of $1,154,516

Steven Gelone Trading

  • Largest purchase of shares was 10,000 units , worth over $38.2K on June 26, 2018
  • In total has made about 44 transactions over 5 years
  • Usually trades in February and August, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Steven Gelone Mailing Address

  • Mailing address is 1000 Continental Drive Suite 600 King of Prussia PA 19406 PA

Nabriva Therapeutics Plc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Theodore Schroeder 2020 $576,800 - $242,256 $339,625 $242,256 $31,759 $1,654,570
Theodore Schroeder 2019 $560,000 - $119,250 $478,367 $119,250 $28,372 $1,496,164
Steven Gelone 2020 $486,300 - $153,185 $231,493 $153,185 $12,675 $1,154,516
Steven Gelone 2019 $472,100 - $181,420 $309,859 $181,420 $13,976 $1,178,280
Jennifer Schranz 2020 $460,000 $100,000 $145,203 $156,818 $145,203 $28,604 $1,074,113
Jennifer Schranz 2019 $436,200 - $151,200 $261,555 $151,200 $33,450 $982,155
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm

Nabriva Therapeutics Plc Insider Trading

  • The most recent transaction was 100,000 units bought on December 29, 2021 by Theodore Schroeder worth over $57.32K
  • In the last 4 years, insiders at Nabriva Therapeutics Plc sold an estimated value of $5.24M and bought an estimated value of $1.22M
  • The most active traders are Steven Gelone, President and COO,  Theodore Schroeder, Chief Executive Officer,  and Robert Crotty, Gen Counsel & Corp Secretary
  • Insider trading is most common in August, with the busiest year in 2021

Nabriva Therapeutics Legacy plc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1